Jacks Lee - 27 Nov 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Jacks Lee, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
27 Nov 2023
Net transactions value
$0
Form type
4
Filing time
29 Nov 2023, 16:49:16 UTC
Previous filing
16 Jun 2023
Next filing
10 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 27 Nov 2023 Common Stock 30,000 $50.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option shall vest over 36 months, 1/3 of which will vest on November 27, 2024 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.